Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice

I. Papazian, E. Tsoukala, A. Boutou, M. Karamita, K. Kambas, L. Iliopoulou, R. Fischer, R. Kontermann, M. Denis, G. Kollias, H. Lassmann, and L. Probert. Journal of neuroinflammation, 18 (1): 222--222 (September 2021)
DOI: 10.1186/s12974-021-02200-4

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Univ. -Prof. Dr. Roland Kontermann University of Stuttgart

E. Garrelts

E. Zafeiriou

Roland Weil University of Stuttgart

apl. Prof. Dr. Roland Gehrke University of Stuttgart

Other publications of authors with the same name

Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension DomainsM. Siegemund, P. Oak, E. Hansbauer, A. Allersdorfer, K. Utschick, A. Winter, C. Grasmüller, G. Galler, J. Mayer, B. Weiche and 3 other author(s). Frontiers in pharmacology, (2021)An optimized antibody-single-chain TRAIL fusion protein for cancer therapyM. Siegemund, O. Seifert, M. Zarani, T. Dzinic, V. De Leo, D. Göttsch, S. Münkel, M. Hutt, K. Pfizenmaier, and R. Kontermann. mAbs, 8 (5): 879-891 (2016)Superior Properties of Fc-comprising scTRAIL Fusion ProteinsM. Hutt, L. Marquardt, O. Seifert, M. Siegemund, I. Müller, D. Kulms, K. Pfizenmaier, and R. Kontermann. Molecular cancer therapeutics, 16 (12): 2792-2802 (2017)Viro-antibody therapy : engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeuticsR. Kontermann, G. Ungerechts, and D. Nettelbeck. mAbs, 13 (1): 1982447 (2021)The making of bispecific antibodiesU. Brinkmann, and R. Kontermann. mAbs, 9 (2): 182-212 (2017)Systemic network analysis identifies XIAP and I kappa B alpha as potential drug targets in TRAIL resistant BRAF mutated melanomaG. Del Mistro, P. Lucarelli, I. Müller, S. De Landtsheer, A. Zinoveva, M. Hutt, M. Siegemund, R. Kontermann, S. Beissert, T. Sauter and 1 other author(s). NPJ systems biology and applications, (2018)The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificityO. Seifert, A. Plappert, N. Heidel, S. Fellermeier, S. Messerschmidt, F. Richter, and R. Kontermann. Protein Engineering, Design and Selection, 25 (10): 603--612 (October 2012)A novel expression and purification system for the production of enzymatic and biologically active human granzyme BM. Gehrmann, B. Doß, M. Wagner, K. Zettlitz, R. Kontermann, G. Foulds, A. Pockley, and G. Multhoff. Journal of Immunological Methods, 371 (1-2): 8--17 (2011)Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityF. Richter, K. Zettlitz, O. Seifert, A. Herrmann, P. Scheurich, K. Pfizenmaier, and R. Kontermann. mAbs, (September 2018)Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes.M. Rothdiener, J. Beuttler, S. Messerschmidt, and R. Kontermann. Methods in molecular biology (Clifton, N.J.), (2010)

PUMA

Disambiguation of "Kontermann, Roland E"